TreeFrog Therapeutics、自社iPSプラットフォームと細胞治療パイプラインの開発を主導する科学諮問委員会を任命

TreeFrog Therapeutics, a French-based biotech aimed at making safer, more efficient and more affordable off-the-shelf cell therapies based on induced pluripotent stem cells (iPSCs), today announces the formation of its Scientific Advisory Board (SAB). Bringing together world-class experts in biophysics, pluripotent stem cell biology and...